Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,250,000,000 Outstanding Principal Amount

March 12, 2018

Responsive image

LAVAL, Quebec, March 12, 2018 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (“Valeant”) and Valeant Pharmaceuticals International (“VPI,” and together with Valeant, the “Offerors”), a wholly owned indirect subsidiary of Valeant, incorporated in…

Category: Precious Metals